Caroline Chung1,
1Radiation Medicine Program, Princess
Margaret Hospital, Toronto, Ontario, Canada; 2SickKids' Hospital,
Toronto, Ontario, Canada; 3SickKids Hospital, Toronto, Onatario,
Canada; 4Brain Tumour Research Centre, Toronto, Ontario, Canada; 5Toronto
Western Hospital, Canada
This
study demonstrates feasibility of using multiparametric micro-MRI to overcome
the challenges of intracranial mouse tumour models. Baseline T2w images were
used to select mice with visible tumours and to stratify mice to treatment
arms based on tumour size. Serial multiparametric MRI was used to measure
tumour growth and vascular changes on DCE-MRI (iAUC60) with radiation (RT)
and/or sunitinib (SU) anti-angiogenic treatment. Early rises in iAUC60 were
noted following both RT and SU monotherapy, while the combination of RT and
SU resulted in an early significant decrease in iAUC60. These early measured
DCE-MRI changes show promise as useful early biomarkers for treatment
response.